文献速递脑血管病

短暂性脑缺血发作或卒中合并多血管床症状性血管疾病患者的长期预后

Long-Term Prognosis of Patients With Transient Ischemic Attack or Stroke and Symptomatic Vascular Disease in Multiple Arterial Beds.
PubMed 文献 · Stroke · 2018-06-07

基于牛津郡人群的牛津血管研究,纳入2002至2014年2554例短暂性脑缺血发作或缺血性卒中患者,随访10 679患者年。结果显示,合并多个血管床症状性病变者5年血管死亡风险随受累血管床数目增加而升高(17.2%对30.0%对42.9%),且复发缺血性卒中和非卒中急性血管事件长期风险更高。

要点

  • 多血管床病变患者5年血管死亡风险随受累血管床数目增加而升高(17.2%对30.0%对42.9%,P<0.0001)。
  • 多血管床病变患者90天至10年复发缺血性卒中风险升高(年龄/性别校正HR 1.38,95%CI 1.04-1.81,P=0.02)。
  • 多血管床病变患者非卒中急性血管事件风险显著升高(HR 3.06,95%CI 2.23-4.20,P<0.0001)。

核心结论

  • 受累血管床数目似乎是识别短暂性脑缺血发作/缺血性卒中患者长期非卒中血管事件和血管死亡高风险的简单临床规则。

研究设计与样本

  • 基于牛津郡92 728人的群体研究(牛津血管研究),纳入2002至2014年就诊的短暂性脑缺血发作/缺血性卒中患者,按其他血管床(冠状动脉、外周)症状性病变数目分为单、双、三血管床病变组,比较危险因素和长期预后。
  • 共纳入2554例患者,随访10 679患者年。

主要发现

  • 1842例(72.1%)为单血管床病变(仅短暂性脑缺血发作/卒中),608例(23.8%)为双血管床病变,104例(4.1%)为三血管床症状性血管病变。
  • 受累血管床数目随动脉粥样硬化危险因素数目增加而增加(P趋势<0.0001)。
  • 与仅短暂性脑缺血发作/卒中患者相比,多血管床病变患者高血压年龄/性别校正OR 3.43(95%CI 2.76-4.27,P<0.0001),糖尿病OR 2.89(95%CI 2.27-3.66,P<0.0001),高胆固醇血症OR 4.67(95%CI 3.85-5.66,P<0.0001),当前或既往吸烟OR 1.52(95%CI 1.26-1.84,P<0.0001)。
  • 三血管床病变与高胆固醇血症关联尤其强(OR 6.80,95%CI 4.39-10.53,P<0.0001)。
  • 尽管多血管床病变患者接受了更强化二级预防,5年血管死亡风险仍随受累血管床数目增加而陡升(单血管床17.2%对双血管床30.0%对三血管床42.9%,P<0.0001)。

临床怎么用

  • 作者认为,受累血管床数目可作为识别短暂性脑缺血发作/缺血性卒中后长期非卒中血管事件和血管死亡高风险患者的简单临床规则。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Cerebrovascular, coronary, and peripheral vascular disease have common underlying arterial pathology and risk factors, but the clinical significance of multiple-territory disease in patients with transient ischemic attack (TIA)/ischemic stroke is unclear, particularly whether the number of clinically affected territories still predicts long-term outcome on current standard secondary prevention therapies. METHODS: In a population-based study of 92 728 individuals in Oxfordshire, United Kingdom (Oxford Vascular Study), we studied patients presenting with TIA/ischemic stroke (2002-2014) in relation to the number of other vascular beds (coronary, peripheral) affected by symptomatic (current or previous) disease. We compared the risk factor profile and long-term prognosis in patients with single- versus multiple-territory disease. RESULTS: Among 2554 patients with 10 679 patient-years of follow-up, 1842 (72.1%) had single- (TIA/stroke only), 608 (23.8%) double-, and 104 (4.1%) triple-territory symptomatic vascular disease. The number of affected vascular beds increased with the number of atherosclerotic risk factors (Ptrend<0.0001). Compared with patients with TIA/stroke only, those with multiple-territory disease had more hypertension (age/sex-adjusted odds ratio [OR], 3.43; 95% confidence interval [CI], 2.76-4.27; P<0.0001), diabetes mellitus (OR, 2.89; 95% CI, 2.27-3.66; P<0.0001), hypercholesterolemia (OR, 4.67; 95% CI, 3.85-5.66; P<0.0001), and current or previous smoking (OR, 1.52; 95% CI, 1.26-1.84; P<0.0001). Triple-territory disease was particularly strongly associated with hypercholesterolemia (OR, 6.80; 95% CI, 4.39-10.53; P<0.0001). Despite more intensive secondary prevention in patients with multiple-territory disease, the 5-year risk of vascular death increased steeply with the number of territories affected (17.2% versus 30.0% versus 42.9%; P<0.0001). Compared with patients with single-territory, patients with multiple-territory disease also had higher postacute long-term risks (90 days to 10 years) of recurrent ischemic stroke (age/sex-adjusted hazard ratio, 1.38; 95% CI, 1.04-1.81; P=0.02) and nonstroke acute vascular events (hazard ratio, 3.06; 95% CI, 2.23-4.20; P<0.0001). CONCLUSIONS: Number of affected vascular beds appeared to be a simple clinical rule in identifying TIA/ischemic stroke patients who are at high long-term risk of nonstroke vascular events and vascular death.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Heldner MR, Li L, Lovett NG, et al. Long-Term Prognosis of Patients With Transient Ischemic Attack or Stroke and Symptomatic Vascular Disease in Multiple Arterial Beds. Stroke. 2018. PMID: 29880551. doi:10.1161/STROKEAHA.118.020913

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。